UNSPSC 51201614: Pertussis vaccine

This classification denotes a vaccine for a respiratory infection caused by bordetella pertussis and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.

UNSPSC 51201614 Pertussis vaccine is a Commodity code that state and local health departments use to procure whooping cough immunizations for public health programs, school entry requirements, and disease-prevention initiatives. The code encompasses finished vaccine products ready for administration in clinical and community settings. Health departments across the United States are the primary issuing bodies under this code, typically pursuing vaccines through cooperative purchasing arrangements, competitive sealed bids, or sole source procurements when clinical or supply-chain factors justify single-vendor designation. Recent solicitation activity shows that state health agencies handle procurement at scale and maintain standing relationships with established vaccine manufacturers to ensure continuity of supply for routine immunization schedules.

The recent opportunities block includes a July 2026 notice from the Mississippi State Department of Health; however, that solicitation targets Yellow Fever Vaccine from Sanofi Pasteur, Inc. (due August 3, 2026), not pertussis vaccine, representing a code-posting mismatch. The Mississippi posting is a sole source objection period rather than a competitive solicitation, with no quantity, term, or estimated value disclosed. No state and local procurements specifically for pertussis vaccine appear in the recent-opportunities block, limiting visibility into current geographic spread, issuing-body repeat patterns, or representative open competitions for this Commodity code. The code shows minimal recent public activity in available state and local contract notices.